Zobrazeno 1 - 10
of 44
pro vyhledávání: '"Ana Vallari"'
Autor:
Kelly E. Coller, Veronica Bruce, Michael Cassidy, Jeffrey Gersch, Matthew B. Frankel, Ana Vallari, Gavin Cloherty, John Hackett, Jennifer L. Evans, Kimberly Page, George J. Dawson
Publikováno v:
Emerging Infectious Diseases, Vol 26, Iss 2, Pp 265-272 (2020)
Most human pegivirus 2 (HPgV-2) infections are associated with past or current hepatitis C virus (HCV) infection. HPgV-2 is thought to be a bloodborne virus: higher prevalence of active infection has been found in populations with a history of parent
Externí odkaz:
https://doaj.org/article/7ee0e28cb7324ddb8c66f4fe44298b71
Autor:
Mary A. Rodgers, Tulio de Oliveira, Ana Vallari, Lazare Kaptue, Carole McArthur, Dennis Maletich Junqueira, Guixia Yu, Gavin Cloherty, Charles Y. Chiu, Eduan Wilkinson, Dora Mbanya, Asmeeta Achari, Xianding Deng
Publikováno v:
AIDS Research and Human Retroviruses
Although the first HIV circulating recombinant form (CRF01_AE) is the predominant strain in many Asian countries, it is uncommonly found in the Congo Basin from where it first originated. To fill the gap in the evolutionary history of this important
Autor:
Gavin Cloherty, Michael Berg, Mary A. Rodgers, Julie Yamaguchi, Larry Sthreshley, Ana Vallari, Carole McArthur
Publikováno v:
Journal of Acquired Immune Deficiency Syndromes (1999)
Background: The full spectrum of HIV-1 diversity can be found in Central Africa, including 2 divergent HIV-1 strains collected in 1983 and 1990 in Democratic Republic of Congo (DRC) that were preliminarily classified as group M subtype L. However, a
Autor:
Michael J. Peluso, Rachel L. Rutishauser, Matthew A Spinelli, Christopher C. Nixon, Mary A. Rodgers, Bryan Greenhouse, Rebecca Hoh, Emily A. Fehrman, Cassandra Thanh, Charles Y. Chiu, John Hackett, Wesley Wu, Timothy J. Henrich, Albert Shu, Viva W. Tai, Theodore W. Kurtz, Mars Stone, Sadie E. Munter, John Prostko, Steven G. Deeks, Isabel Rodriguez-Barraquer, Jeffrey N. Martin, J. Daniel Kelly, Leonel Torres, Joanna Donatelli, Jeffrey I. Cohen, Peter D. Burbelo, Jill Hakim, Philip J. Norris, Michael P. Busch, Saki Takahashi, Terri Wrin, Monica Gandhi, Lan Trinh, James A. Wells, Yanel Hernandez, Keirstinne Turcios, John E. Pak, Ana Vallari, Nikita S. Iyer, Owen Janson, Xin X. Zhou, Clara DiGermanio, Susanna K. Elledge, Mary-Ann Palafox, Christos J. Petropoulos
Publikováno v:
medRxiv
Science Advances
Science advances, vol 7, iss 31
Science Advances
Science advances, vol 7, iss 31
Antibody detection of prior SARS-CoV-2 infection depends on severity, assay, and timing with implications for serosurveillance.
Interpretation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) serosurveillance studies is limited by
Interpretation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) serosurveillance studies is limited by
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c3321f257b2c3e566f9202630b6f169
https://europepmc.org/articles/PMC7941652/
https://europepmc.org/articles/PMC7941652/
Autor:
Christopher D Pilcher, Brian Louie, Shelley Facente, Sheila Keating, John Hackett, Ana Vallari, Chris Hall, Teri Dowling, Michael P Busch, Jeffrey D Klausner, Frederick M Hecht, Sally Liska, Mark W Pandori
Publikováno v:
PLoS ONE, Vol 8, Iss 12, p e80629 (2013)
BackgroundCurrent laboratory and point-of-care tests for HIV detect different analytes and use different sample types. Some have fast turnaround times (MethodsWe analyzed 21,234 consecutive HIV tests with venous blood obtained by San Francisco HIV te
Externí odkaz:
https://doaj.org/article/898caf193bd94211b5400e2294bc530d
Autor:
Sandra Pearce, Mary A. Rodgers, Gavin Cloherty, Luis Gonzalez Olivieri, Sam Douthwaite, Delfin Rubin, John Prostko, Gaia Nebbia, Ana Olivo, Ana Vallari, Rahul Batra
Publikováno v:
Journal of Clinical Virology
Introduction Antibodies to SARS-CoV-2 serve as critical diagnostic markers for determining how broadly the COVID-19 pandemic has spread, confirming patient recovery, monitoring potential long-term effects of infection, and evaluating potential protec
Autor:
Mary A. Rodgers, Shruti H. Mehta, Selvamurthi Gomathi, Gavin Cloherty, Ana Vallari, Sunil S. Solomon, Shanmugam Saravanan, Gregory M. Lucas
Publikováno v:
Scientific Reports
Scientific Reports, Vol 10, Iss 1, Pp 1-9 (2020)
Scientific Reports, Vol 10, Iss 1, Pp 1-9 (2020)
Although the prevalences of HIV and HCV are significantly higher amongst PWID in India compared to the general population, the strains circulating within this group have not been well-characterized. Through subgenomic sequencing of viruses present in
Hepatitis C virus surveillance and identification of human pegivirus 2 in a large Cameroonian cohort
Autor:
Jill Fuhrman, Mary A. Rodgers, Kenn Forberg, Matthew Frankel, Michael Berg, Gavin Cloherty, Ana Olivo, Ana Vallari, Kelly E. Coller, Vera Holzmayer, Dora Mbanya, Nicaise Ndembi, Jules Bertrand Kenmegne Sidje, Bih Awazi
Publikováno v:
Journal of Viral Hepatitis
Summary The prevalence of chronic hepatitis C virus (HCV) and the presence of human pegivirus 2 (HPgV‐2) have not been examined in Cameroon, although HCV has been associated with HPgV‐2 infections previously. Herein we aimed to characterize the b
ARCHITECT HIV Combo Ag/Ab and RealTime HIV-1 Assays Detect Diverse HIV Strains in Clinical Specimens
Autor:
Mary A. Rodgers, Carole McArthur, Vera Holzmayer, Samar Badreddine, Gavin Cloherty, Nicaise Ndembi, Dora Ngum Mbanya, Julie Yamaguchi, Souleymane Mboup, Lazare Kaptue, Coumba Toure-Kane, Ana Vallari, Barbara J. Harris
Publikováno v:
AIDS Research and Human Retroviruses
Periodic evaluation of the impact of viral diversity on diagnostic tests is critical to ensure current technologies are keeping pace with viral evolution. To determine whether HIV diversity impacts the ARCHITECT HIV Combo Ag/Ab (HIV Combo) or RealTim
Autor:
Gavin A. Cloherty, James N. Moy, Russell H. Taylor, Ana Vallari, Mark C Anderson, Vera Holzmayer
Publikováno v:
Journal of Clinical Virology
Serologic testing for SARS-CoV-2 antibodies can be used to confirm diagnosis, estimate seroprevalence, screen convalescent plasma donors, and assess vaccine efficacy. Several logistical and infrastructure challenges limit access to SARS-CoV-2 serolog